Менеджер – это такой специалист, который профессионально занимается управленческой деятельностью в конкретной области функционирования организации. Но быть менеджером – это разделять ответственность за успешность организации в целом. Менеджеры представляют собой основной ресурс любой организации.

Менеджер

Officials said several key targets were struck during the operation. Among them were a command center and a storage facility believed to contain unmanned aerial vehicles. Southern districts of the Lebanese capital have repeatedly come under airstrikes in recent months. Israel says the operations are aimed at destroying militant infrastructure and preventing potential drone attacks. Information about possible damage and casualties from the latest strikes is still being clarified.Powered by <a href="https://www.froala.com/wysiwyg-editor?pb=1" title="Froala Editor">Froala Editor</a>

The Israeli military carried out a new series of airstrikes on the southern suburbs of Beirut. According to the army’s statement, this marked the 26th wave of attacks targeting the area.

26th Wave of Strikes: Israel Hits Southern Beirut

The ceremony was attended by the leadership of the Ministry of Internal Affairs of Uzbekistan, representatives of the public, Eshnazarov&rsquo;s colleagues, and members of his family. During the event, a memorial plaque bearing the names of officers who lost their lives while performing their duties was presented. Participants laid wreaths and paid tribute to the fallen. Officials emphasized that Khosilbek Eshnazarov&rsquo;s dedication and courage serve as an example for law enforcement officers. One of his colleagues noted that he stopped a criminal at the cost of his own life, preventing potentially more tragic consequences. According to a presidential decree, Junior Sergeant Khosilbek Eshnazarov was posthumously awarded the &ldquo;Jasorat&rdquo; (Courage) medal. The award was presented to his father by the Minister of Internal Affairs. The state has also guaranteed social support for the officer&rsquo;s family. They have been provided with a three-room apartment, free access to medical services in departmental facilities, and assistance for the higher education of his daughter and two sons. In addition, a monument to the traffic patrol service inspector Khosilbek Eshnazarov will be installed at School No. 62 in Guzar district of Kashkadarya region as a symbol of loyalty to the Motherland and duty. According to the Ministry of Internal Affairs, 118 officers of Uzbekistan&rsquo;s internal affairs bodies have died in the line of duty since the country gained independence. The name of Khosilbek Eshnazarov now joins the ranks of those heroes.Powered by <a href="https://www.froala.com/wysiwyg-editor?pb=1" title="Froala Editor">Froala Editor</a>

A memorial complex dedicated to Khosilbek Eshnazarov, an officer who heroically died in the line of duty, has been unveiled at the Main Directorate of Internal Affairs in Tashkent.

Memorial to Officer Khosilbek Eshnazarov Unveiled in Tashkent

According to the Ministry of Transport, 7,988 passengers were returned from Medina and Jeddah through 36 flights. An additional 838 citizens were brought back from Dubai via five flights. Currently, Uzbek airlines continue operating additional evacuation flights. Three flights are being operated on the Dubai&ndash;Tashkent route, while two flights are being conducted on the Jeddah&ndash;Tashkent and Jeddah&ndash;Samarkand routes. Evacuation flights are being organized from countries whose airspace is open for civil aviation. At the same time, negotiations are ongoing with the aviation authorities of Qatar, Bahrain, and Kuwait. Charter flights are expected to be arranged in the coming days to return citizens from these countries as well.Powered by <a href="https://www.froala.com/wysiwyg-editor?pb=1" title="Froala Editor">Froala Editor</a>

Uzbekistan’s resident airlines have carried out 41 evacuation flights to bring citizens back from Middle Eastern countries.

Uzbekistan continues evacuation of citizens from the Middle East

It is noted that Sherzodkhon Kudratkhodja made a significant contribution to the development of the country&rsquo;s media sector, strengthening principles of openness and transparency, and supporting freedom of speech. The association expressed gratitude for his work. Odiljon Tojiev, a member of the Legislative Chamber of the Oliy Majlis Committee on Labour, Healthcare and Social Issues, has been appointed as the new chairman of the board.Powered by <a href="https://www.froala.com/wysiwyg-editor?pb=1" title="Froala Editor">Froala Editor</a>

Sherzodkhon Kudratkhodja has been relieved from the position of Chairman of the Board of the National Media Association of Uzbekistan. The press service of the organization reported this.

Sherzodkhon Kudratkhodja steps down as media association head

The head of state noted that the pharmaceutical industry is strategically important, as it directly impacts public health, quality of life, and the country&#39;s economic security. It was noted that significant opportunities for the sector&#39;s development have been created in recent years. Specifically, over the past nine years, $1.8 billion has been invested in the industry, and 140 new production facilities have been launched. Today, more than 300 pharmaceutical companies operate in the country, 58 of which are directly involved in drug production. As a result, pharmaceutical production increased 3.5-fold, exceeding 7 trillion 300 billion soums. Domestic drug production has doubled. Pharmaceutical products manufactured in Uzbekistan are exported to 55 countries. The number of jobs in the industry has exceeded 40,000. Overall, the pharmaceutical and medical device market in our country has reached approximately $2.5 billion. It was emphasized that this year, policymakers face the task of attracting at least $1 billion in investment into the pharmaceutical industry, increasing the share of domestically produced pharmaceuticals in the domestic market to 70 percent by 2030 through quality improvements and the launch of new facilities in partnership with foreign companies, and increasing export volumes to $1 billion over the next five years. Five pharmaceutical industrial zones have been established in the republic, covering 136 hectares, and all the necessary infrastructure has been created. However, in some regions, these opportunities are being utilized ineffectively. For example, the Jizzakh pharmaceutical zone, which occupies 25 hectares, did not produce a single batch of products last year. A 14-hectare site in the Bostanlyk pharmaceutical zone has remained unused since 2017. It was also noted that last year, not a single enterprise was launched in the Jizzakh and Samarkand pharmaceutical zones, while very few investment projects were implemented in the Bukhara and Khorezm pharmaceutical zones. The meeting also considered proposals from pharmaceutical industry entrepreneurs. Specifically, the issue of applying tax breaks provided for pharmaceutical zones to enterprises located in regions where such zones do not exist was raised. The President supported this proposal and announced a number of new opportunities for pharmaceutical manufacturers. Specifically, starting April 1 of this year, new projects for the production of pharmaceuticals and the cultivation and processing of medicinal plants, regardless of location, will be exempt from land tax for three years. After the project begins, profit and property taxes will also be waived for three years. Furthermore, the import of raw materials, equipment, and components for manufacturers of dietary supplements and cosmetics will be exempt from duties. Pharmaceutical companies will be allowed to produce dietary supplements on their own production lines. A list of medicines and medical devices recommended for localization will now be published for entrepreneurs by July 1. Entrepreneurs will be provided with foreign currency loans at 7 percent interest for projects manufacturing products from this list. Enterprises planning to further localize existing products will be provided with loans from the Industrial Cooperation Fund for up to 10 years at a rate of 6 percent in foreign currency and 12 percent in national currency. The meeting also focused on attracting foreign pharmaceutical companies to our country and establishing technology transfers with them. It was noted that almost half of imported medicines are produced by 34 foreign companies. Therefore, it is necessary to encourage their production in Uzbekistan. Large enterprises involved in importing medicines are also recommended to increase social responsibility and take the initiative to establish production of branded medicines in our country. To stimulate this process, the royalty tax paid by enterprises for the use of foreign brands will be reduced from 20 to 5 percent. Twenty to 25 years after the creation of an original drug, other pharmaceutical companies are granted the right to produce it. Developing such drugs allows for several-fold reductions in domestic market prices. In this regard, companies that master the production of in-demand drugs within a year will receive half of their technology transfer costs from the Fund for Support and Development of the Pharmaceutical Industry. Furthermore, to expand production of the 100 most frequently imported medications, the Tashkent Pharma Park pharmaceutical cluster will be expanded by another 100 hectares. The meeting also addressed pharmaceutical exports. Although industry exports have reached $220 million, only $14 million of this amount is for pharmaceuticals. In this regard, the importance of ensuring that enterprises operate in accordance with international standards was emphasized. Currently, all 58 pharmaceutical companies have national GMP certificates. It was noted that they now need to align their operations with European GMP standards. Starting June 1, 50 percent of the costs of obtaining Euro GMP certification for local enterprises will be reimbursed by the Trade Facilitation Fund. The meeting also discussed expanding the participation of domestic manufacturers in the public procurement system. It was noted that some enterprises are unable to supply products to government agencies because their localization level is below 30 percent. In this regard, entrepreneurs with a domestic manufacturer&#39;s certificate, regardless of the level of localization, will be allowed to participate in public procurement until September 1. As noted, more than 57,000 unregistered and counterfeit medicines were identified in our country last year. In this regard, the importance of developing a bill to tighten penalties for the illegal trade in medicines and the circulation of products of dubious quality was emphasized. The meeting also raised the issue of bridging the gap between science and local production. Currently, more than 300 scientists work in six industry research institutes, and higher education institutions annually train nearly 1,000 specialists. However, the implementation of scientific research into practice is insufficient. In this regard, a National Research Institute of Biopharmaceuticals will be established on the premises of the Institutes of Chemistry and Pharmaceutics, Vaccines and Serums, and Oriental Medicine. It will be located within the Tashkent Pharma Park cluster, which will allow for the direct integration of research and production. The park will house a preclinical research laboratory, biological and chemical research centers, and a 250-bed international clinical research center. Furthermore, professors and teachers from the Tashkent Pharmaceutical Institute and the Pharmaceutical Technical University will conduct their research activities within the pharmaceutical park. Students will have the opportunity to study and work at these companies through dual education. Companies will be reimbursed for up to $100,000 in expenses for projects to produce new drugs with the participation of external scientists. Companies establishing production of new drugs developed by domestic scientists will receive a subsidy of up to 100 million soums to cover their registration and clinical trial costs. The meeting heard proposals and initiatives from pharmaceutical company representatives, reports from responsible officials, and issued relevant instructions to ensure the implementation of these tasks.Powered by <a href="https://www.froala.com/wysiwyg-editor?pb=1" title="Froala Editor">Froala Editor</a>

On March 5, President Shavkat Mirziyoyev chaired a videoconference on expanding production and accelerating the implementation of advanced technologies in the pharmaceutical industry.

Increasing Production and Accelerating Technology Transfer in the Pharmaceutical Industry Discussed

The event was organized by Ministry of Investment, Industry and Trade of Uzbekistan and served as a platform to discuss new directions of investment and technological cooperation. The Uzbek delegation was led by Deputy Minister Ilzat Kasimov of the ministry. The forum was attended by representatives of government agencies, Uzbekistan Agency for Perspective Projects, Chamber of Commerce and Industry of Uzbekistan, IT Park Uzbekistan and infrastructure organizations. The Japanese side was represented by Deputy Minister of Land, Infrastructure, Transport and Tourism of Japan Yoshimichi Terada, and the Ambassador of Japan to Uzbekistan Kenji Hirata, along with major Japanese companies including Hankyu, Shimizu Corporation, Nikken Sekkei, Itochu, Marubeni, Sojitz Corporation and Oriental Consultants Global. In 2025, bilateral trade turnover reached about 400 million USD. The number of enterprises with Japanese capital increased nearly tenfold over 8 years, reaching 130 companies. The forum discussed joint projects in intelligent transport systems, municipal infrastructure modernization, digital urban environment monitoring, public transport development and sustainable urban planning.Powered by <a href="https://www.froala.com/wysiwyg-editor?pb=1" title="Froala Editor">Froala Editor</a>

An Uzbekistan–Japan business forum dedicated to the development of smart cities and urban technology implementation was held in Tashkent on March 4.

Japanese Technologies for Tashkent: Business Forum Opens New Projects

In an interview with Fox News, the US leader said that, according to American assessments, Iran was nearing the final stage of producing a nuclear warhead. &ldquo;If we had not done this, within two weeks they would have had a nuclear warhead. After that, nothing that is happening now would have been possible,&rdquo; Trump said. According to the president, this assessment was the key factor behind the decision to launch the strike. Washington believes the operation prevented a new and more dangerous phase of escalation in the region. No official response from Tehran to these statements had been reported at the time of publication.Powered by <a href="https://www.froala.com/wysiwyg-editor?pb=1" title="Froala Editor">Froala Editor</a>

В интервью телеканалу Fox News глава Белого дома подчеркнул, что, по оценке американской стороны, Иран находился на завершающей стадии разработки ядерной боеголовки. &laquo;Если бы мы этого не сделали, через две недели у них была бы ядерная боеголовка. А после этого ничего из происходящего уже не было бы возможным&raquo;, &mdash; заявил Трамп. По словам президента, именно этот фактор стал ключевым при принятии решения о нанесении удара. В Вашингтоне считают, что операция позволила предотвратить качественно новый этап эскалации в регионе. Официальная реакция Тегерана на данные заявления на момент публикации материала не приводится.Powered by <a href="https://www.froala.com/wysiwyg-editor?pb=1" title="Froala Editor">Froala Editor</a>

Президент США Дональд Трамп заявил, что решение о совместной с Израилем военной операции против Ирана было принято из-за угрозы создания Тегераном ядерного оружия в ближайшие недели.

«Две недели до бомбы»: Трамп объяснил удар по Ирану

US President Donald Trump stated that the joint US-Israeli military operation against Iran was driven by the threat of Tehran developing nuclear weapons within weeks.

“Two Weeks to a Bomb”: Trump Explains Strike on Iran

Fox News telekanaliga bergan intervyusida Oq uy rahbari AQSh bahosiga ko&lsquo;ra, Eron yadro kallagini yaratishning yakuniy bosqichiga yaqinlashganini aytdi. &ldquo;Biz buni qilmaganimizda, ikki hafta ichida ularda yadro kallagi bo&lsquo;lardi. Shundan keyin hozir sodir bo&lsquo;layotgan voqealar umuman mumkin bo&lsquo;lmas edi&rdquo;, &mdash; dedi Tramp. Uning so&lsquo;zlariga ko&lsquo;ra, aynan shu omil zarba berish haqidagi qarorni qabul qilishda hal qiluvchi ahamiyat kasb etgan. Vashington operatsiya mintaqadagi keskinlashuvning yangi bosqichini oldini olganini ta&rsquo;kidlamoqda. Mazkur bayonotlarga Tehronning rasmiy munosabati hozircha keltirilmagan.Powered by <a href="https://www.froala.com/wysiwyg-editor?pb=1" title="Froala Editor">Froala Editor</a>

AQSh prezidenti Donald Tramp Eron va Isroil bilan birgalikda o‘tkazilgan harbiy operatsiya qarori Tehron yaqin haftalarda yadro qurolini yaratishi mumkinligi bilan bog‘liq bo‘lganini ma’lum qildi.

“Bombagacha ikki hafta”: Tramp Eron bo‘yicha zarbani izohladi

Фoх Неwс телеканалига берган интервюсида Oқ уй раҳбари АҚШ баҳoсига кўра, Эрoн ядрo каллагини яратишнинг якуний бoсқичига яқинлашганини айтди. «Биз буни қилмаганимизда, икки ҳафта ичида уларда ядрo каллаги бўларди. Шундан кейин ҳoзир сoдир бўлайoтган вoқеалар умуман мумкин бўлмас эди», &quot; деди Трамп. Унинг сўзларига кўра, айнан шу oмил зарба бериш ҳақидаги қарoрни қабул қилишда ҳал қилувчи аҳамият касб этган. Вашингтoн oператсия минтақадаги кескинлашувнинг янги бoсқичини oлдини oлганини та&rdquo;кидламoқда. Мазкур байoнoтларга Теҳрoннинг расмий мунoсабати ҳoзирча келтирилмаган.Пowеред бй <a href="https://www.froala.com/wysiwyg-editor?pb=1" title="Froala Editor">Фрoала Эдитoр</a>

АҚШ президенти Дoналд Трамп Эрoн ва Исрoил билан биргаликда ўтказилган ҳарбий oператсия қарoри Теҳрoн яқин ҳафталарда ядрo қурoлини яратиши мумкинлиги билан бoғлиқ бўлганини маълум қилди.